R1 RCM Inc. (NASDAQ:RCM – Get Free Report) has been assigned an average rating of “Hold” from the eighteen analysts that are covering the stock, Marketbeat.com reports. Thirteen equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $15.79.
A number of research analysts have weighed in on the stock. Leerink Partnrs lowered shares of R1 RCM from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Jefferies Financial Group downgraded R1 RCM from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Stephens cut R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 1st. Royal Bank of Canada reiterated an “outperform” rating and set a $19.00 price target on shares of R1 RCM in a report on Friday, June 28th. Finally, Morgan Stanley lowered shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 8th.
View Our Latest Stock Report on RCM
Institutional Trading of R1 RCM
R1 RCM Stock Up 0.4 %
Shares of RCM opened at $14.04 on Tuesday. The stock has a 50 day moving average price of $12.92 and a 200 day moving average price of $12.62. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.79 and a current ratio of 1.79. The stock has a market capitalization of $5.91 billion, a price-to-earnings ratio of -175.50 and a beta of 0.85. R1 RCM has a one year low of $8.87 and a one year high of $18.22.
R1 RCM (NASDAQ:RCM – Get Free Report) last released its earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03. The business had revenue of $627.90 million during the quarter, compared to analyst estimates of $633.10 million. R1 RCM had a negative net margin of 1.39% and a negative return on equity of 1.16%. The business’s revenue was up 12.0% compared to the same quarter last year. Equities research analysts forecast that R1 RCM will post -0.2 earnings per share for the current fiscal year.
R1 RCM Company Profile
R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.
Featured Stories
- Five stocks we like better than R1 RCM
- Market Cap Calculator: How to Calculate Market Cap
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- 10 Best Airline Stocks to Buy
- 2 Option Strategies to Maximize Profits in a Bear Market
- About the Markup Calculator
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.